fda warning unapproved peptides bpc-157 tb-500 compounding Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY ⬇️ Health advisers begin meeting Thursday

Health advisers begin meeting Thursday to review more than a half dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. The FDA just put peptides like BPC 157, TB 500, and KPV on the clock. As a compounding pharmacist, this is literally my world and most people don't understand the regulatory nuance behind The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link A panel of outside advisers will review seven peptides at a meeting in July to determine if the unapproved drugs can be safely produced by pharmacies.

SKU: 69803991683 · From webdevsolutions.tech